Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Bogdahn

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Der Internist|March 5, 2004
["Tingling feet," forgetfulness, and progressive personality changes in a 63-year-old patient]T Karrasch, M Weil, R Voltz, et al.
Der Nervenarzt|June 7, 2012
[Indications and outcome of ventilated patients treated in a neurological intensive care unit]D Steffling, M Ritzka, W Jakob, et al.
Der Radiologe|November 1, 2000
[Carotid endarterectomy and carotid stenting. A pilot study of a prospective, randomized and controlled comparison]J Link, C Manke, L Rosin, et al.
Neurology|February 28, 2007
Safety and feasibility of long-term temozolomide treatment in patients with high-grade gliomaP Hau, D Koch, T Hundsberger, et al.
Neurology|April 12, 2006
Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndromeG Uyanik, N Elcioglu, J Penzien, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 9, 2000
Transcranial Doppler ultrasonography: year 2000 updateV L Babikian, E Feldmann, L R Wechsler, et al.
Neuro-Oncology|October 29, 2010
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyU Bogdahn, P Hau, G Stockhammer, et al.
Neurology|September 2, 2011
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastomaM Weller, T Gorlia, J G Cairncross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor GroupR Stupp, A Tosoni, J E C Bromberg, et al.
Neurological Research and Practice|December 16, 2020
The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trialU Meyding-Lamadé, C Jacobi, F Martinez-Torres, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Der Internist|March 5, 2004
["Tingling feet," forgetfulness, and progressive personality changes in a 63-year-old patient]T Karrasch, M Weil, R Voltz, et al.
Der Nervenarzt|June 7, 2012
[Indications and outcome of ventilated patients treated in a neurological intensive care unit]D Steffling, M Ritzka, W Jakob, et al.
Der Radiologe|November 1, 2000
[Carotid endarterectomy and carotid stenting. A pilot study of a prospective, randomized and controlled comparison]J Link, C Manke, L Rosin, et al.
Neurology|February 28, 2007
Safety and feasibility of long-term temozolomide treatment in patients with high-grade gliomaP Hau, D Koch, T Hundsberger, et al.
Neurology|April 12, 2006
Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndromeG Uyanik, N Elcioglu, J Penzien, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 9, 2000
Transcranial Doppler ultrasonography: year 2000 updateV L Babikian, E Feldmann, L R Wechsler, et al.
Neuro-Oncology|October 29, 2010
Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb studyU Bogdahn, P Hau, G Stockhammer, et al.
Neurology|September 2, 2011
Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastomaM Weller, T Gorlia, J G Cairncross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor GroupR Stupp, A Tosoni, J E C Bromberg, et al.
Neurological Research and Practice|December 16, 2020
The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trialU Meyding-Lamadé, C Jacobi, F Martinez-Torres, et al.
Pageof 13